Raymond James & Associates’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,907
Closed -$219K 4007
2024
Q1
$219K Sell
7,907
-2,129
-21% -$55.7K ﹤0.01% 3569
2023
Q4
$245K Sell
10,036
-6,299
-39% -$143K ﹤0.01% 3406
2023
Q3
$366K Buy
16,335
+342
+2% +$8.26K ﹤0.01% 3069
2023
Q2
$409K Sell
15,993
-7,675
-32% -$182K ﹤0.01% 3055
2023
Q1
$560K Buy
23,668
+8,878
+60% +$204K ﹤0.01% 2849
2022
Q4
$323K Sell
14,790
-21,315
-59% -$526K ﹤0.01% 3172
2022
Q3
$882K Sell
36,105
-33,017
-48% -$914K ﹤0.01% 2480
2022
Q2
$1.86M Sell
69,122
-15,926
-19% -$512K ﹤0.01% 2028
2022
Q1
$3.33M Sell
85,048
-17,391
-17% -$675K ﹤0.01% 1791
2021
Q4
$4.7M Sell
102,439
-3,981
-4% -$190K ﹤0.01% 1592
2021
Q3
$5.04M Buy
106,420
+10,051
+10% +$470K ﹤0.01% 1489
2021
Q2
$4.47M Sell
96,369
-348
-0.4% -$15.8K ﹤0.01% 1558
2021
Q1
$4.24M Buy
96,717
+3,666
+4% +$166K ﹤0.01% 1526
2020
Q4
$3.82M Buy
93,051
+13,259
+17% +$517K ﹤0.01% 1486
2020
Q3
$2.98M Buy
79,792
+3,969
+5% +$146K ﹤0.01% 1514
2020
Q2
$2.61M Sell
75,823
-13,607
-15% -$423K ﹤0.01% 1566
2020
Q1
$2.5M Sell
89,430
-136,592
-60% -$4.55M ﹤0.01% 1445
2019
Q4
$7.85M Sell
226,022
-80,169
-26% -$2.71M 0.01% 1001
2019
Q3
$9.88M Buy
306,191
+20,066
+7% +$686K 0.01% 872
2019
Q2
$9.81M Buy
286,125
+13,960
+5% +$470K 0.01% 868
2019
Q1
$9.12M Buy
272,165
+108,091
+66% +$3.4M 0.01% 870
2018
Q4
$4.53M Sell
164,074
-79,959
-33% -$2.48M 0.01% 1160
2018
Q3
$9.38M Buy
244,033
+66,546
+37% +$2.45M 0.01% 861
2018
Q2
$6.23M Buy
177,487
+118,158
+199% +$4.12M 0.01% 1060
2018
Q1
$1.98M Buy
59,329
+40,736
+219% +$1.39M ﹤0.01% 1714
2017
Q4
$617K Buy
+18,593
New +$618K ﹤0.01% 2409
2017
Q1
Sell
-10,377
Closed -$251K 3329
2016
Q4
$251K Buy
10,377
+52
+0.5% +$1.22K ﹤0.01% 2757
2016
Q3
$243K Sell
10,325
-255
-2% -$5.86K ﹤0.01% 2752
2016
Q2
$227K Sell
10,580
-375
-3% -$7.9K ﹤0.01% 2574
2016
Q1
$231K Sell
10,955
-550
-5% -$11.1K ﹤0.01% 2495
2015
Q4
$255K Buy
+11,505
New +$264K ﹤0.01% 2255

Other funds holding FFTY

Raymond James & Associates's FFTY Position: Q2 2024 in Review

Raymond James & Associates sold out of CapForce IBD 50 ETF (FFTY) in Q2 2024, closing a stake of 7,907 shares — an estimated $219K sold.

Raymond James & Associates first reported a position in FFTY in Q4 2015 and held it in 31 quarters. The position peaked at $9.88M in Q3 2019. 36 funds tracked by Wall St. Rank hold FFTY as of Q2 2024.

  • Raymond James & Associates reported no remaining CapForce IBD 50 ETF position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 7,907 CapForce IBD 50 ETF shares in Q2 2024, an estimated $219K.
  • Raymond James & Associates first reported a position in CapForce IBD 50 ETF in Q4 2015 and held it in 31 quarters.
  • Raymond James & Associates's CapForce IBD 50 ETF position peaked at $9.88M in Q3 2019.
  • 36 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.